The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development ...

With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...

New Jersey's pharmaceutical industry supports 370,000 jobs and generates $130 billion a year, or 20% of the state's economy. It already faced pushback in recent years from Democrats such as former ...

In this article, we are going to take a look at where Biohaven Ltd. (NYSE:BHVN) stands against other stocks with heavy insider buying in 2025. Insider trading is often seen as an important ...

We recently published a list of 12 Stocks with Heavy Insider Buying in 2025. In this article, we are going to take a look at where Biohaven Ltd. (NYSE:BHVN) stands against other stocks with heavy ...

Highlights,Institutional firms have modified their holdings in Biohaven Ltd., contributing to shifts in stock ownership.,Biohaven’s stock performance reflects fluctuations, with market participation ...

Piper Sandler analyst Allison Bratzel maintained a Buy rating on Biohaven Ltd. (BHVN – Research ... focusing on stocks such as Argenx Se, Ionis Pharmaceuticals, and Cogent Biosciences.

HC Wainwright reissued their buy rating on shares of Biohaven (NYSE:BHVN – Free Report) in a report issued on Tuesday,Benzinga reports. The firm currently has a $54.00 price target on the stock.

DUBLIN and DURHAM, N.C., March 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") and Chimerix (Nasdaq: CMRX) ("Chimerix ...

Biohaven Ltd. (BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat... ByInvesting ...